Feature Channels: Autoimmune Diseases

Filters close

Not for public release

This news release is embargoed until 20-May-2024 5:00 PM EDT Released to reporters: 14-May-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-May-2024 9:10 AM EDT
Mayo Clinic Laboratories and Progentec Diagnostics Launch Lupus Advanced Biomarker Testing Services
Mayo Clinic

As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, Progentec’s proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are available.

Released: 10-Apr-2024 4:05 PM EDT
The Autoimmune Association Announces the Inaugural Young Adult Advisory Council
Autoimmune Association

The Autoimmune Association The Autoimmune Association, the world’s leading nonprofit organization dedicated to autoimmune advocacy, awareness, education, and research, announces the 16 individuals appointed to the newly established Young Adult Advisory Council (YAAC), dedicated to empowering and advocating for young individuals aged 15 to 25 living with autoimmune disease.

Not for public release

This news release is embargoed until 4-Mar-2024 5:00 PM EST Released to reporters: 27-Feb-2024 2:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Mar-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: cells-13-00077-ag.png?1703905384
Released: 28-Feb-2024 3:05 AM EST
Biochemists discover what affects the development of autoimmune diseases
Scientific Project Lomonosov

The biochemist of RUDN University and Institute of Biomedical Chemistry was the first to study how variants of the protein that controls T-lymphocytes affect the development of autoimmune diseases using the example of multiple sclerosis. This will help find new approaches to the treatment of autoimmune diseases.

Released: 23-Feb-2024 1:05 PM EST
Researchers identify new choice of therapy for rare autoimmune disease EGPA
McMaster University

An international team, including researchers from McMaster University and St. Joseph’s Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior to mepolizumab in the treatment of EGPA.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 1:05 AM EST
The immune system’s moonlighters
Cold Spring Harbor Laboratory

Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies.

Not for public release

This news release is embargoed until 19-Feb-2024 5:00 PM EST Released to reporters: 13-Feb-2024 2:05 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 19-Feb-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 13-Feb-2024 8:05 PM EST
Better diagnosis and treatment of cryptococcosis
University of Cologne

A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Released: 12-Feb-2024 10:05 AM EST
Encefalite: Especialista da Mayo Clinic explica por que o tratamento precoce é importante
Mayo Clinic

A Encefalite é uma doença que envolve a inflamação ou inchaço do cérebro. Isso pode acontecer devido a infecções ou problemas no sistema imunológico, e o tratamento precoce é importante.

Released: 12-Feb-2024 10:05 AM EST
التهاب الدماغ: يشرح خبير من مايو كلينك سبب أهمية العلاج المبكر
Mayo Clinic

التهاب الدماغ هو مرض ينطوي على التهاب أو تورم الدماغ. ويمكن أن يحدث بسبب التهابات أو مشكلات تصيب الجهاز المناعي، والعلاج المبكر لتلك الحالة مهم. يقول ساروش إيراني، بكالوريوس الطب والجراحة.، طبيب الأعصاب، وباحث في مايو كلينك في جاكسونفيل، فلوريدا أنه لهذا السبب من الضروري رفع مستوى الوعي.

Released: 12-Feb-2024 10:05 AM EST
Encefalitis: Experto de Mayo Clinic explica por qué es importante el tratamiento temprano
Mayo Clinic

La Encefalitis es una enfermedad que implica inflamación o hinchazón del cerebro. Esto puede suceder debido a infecciones o problemas con el sistema inmunológico, y el tratamiento temprano es importante.

Released: 8-Feb-2024 8:50 AM EST
Atlantic Health System Enrolls First U.S. Patient in Lupus Treatment Trial
Atlantic Health System

NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T) cells in the treatment of the autoimmune disease lupus.

Released: 31-Jan-2024 12:05 PM EST
Autoimmune disease and pregnancy
Institute for Systems Biology

For many aspiring mothers with autoimmune disease, pregnancy can be daunting and full of unknowns.

Newswise: New biomarkers for active lupus nephritis discovered
Released: 22-Jan-2024 4:05 PM EST
New biomarkers for active lupus nephritis discovered
University of Houston

New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.

Newswise: Bioengineered approach shows promise in ulcerative colitis
Released: 16-Jan-2024 10:05 AM EST
Bioengineered approach shows promise in ulcerative colitis
UT Southwestern Medical Center

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis.

Released: 11-Jan-2024 10:05 AM EST
CD4+ T cell patterns linked to autoimmune disorders
Osaka University

Researchers from Osaka University find characteristic changes in CD4+ T cell categories and gene programs associated with autoimmune disease.

Released: 8-Jan-2024 4:05 PM EST
UTHealth Houston study: EBV-specific T-cells play key role in development of multiple sclerosis
University of Texas Health Science Center at Houston

The body’s immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: NUS researchers develop an innovative and flexible method to study immune cell capabilities
Released: 17-Dec-2023 9:05 PM EST
NUS researchers develop an innovative and flexible method to study immune cell capabilities
National University of Singapore (NUS)

Researchers from the National University of Singapore (NUS) devise a simple and innovative way to directly identify and sort the immune cells involved in cell-mediated cytotoxicity.

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 16-Nov-2023 3:05 AM EST
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
Mass General Brigham

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.

Newswise: Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Released: 14-Nov-2023 10:00 AM EST
Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Johns Hopkins Medicine

For years, researchers and clinicians have known that lupus, an autoimmune condition, occurs in women at a rate nine times higher than in men.

Released: 7-Nov-2023 10:05 AM EST
Mayo Clinic Laboratories and Progentec® collaborate to bring advanced biomarker testing services to patients with autoimmune diseases
Mayo Clinic

Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market.

Released: 1-Nov-2023 7:05 PM EDT
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
University of Chicago Medical Center

A new study led by researchers at UChicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin.

Newswise: Repurposed drug offers new potential for managing type 1 diabetes
Released: 1-Nov-2023 4:05 PM EDT
Repurposed drug offers new potential for managing type 1 diabetes
Indiana University

A new study published in Cell Reports Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The study's findings' suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies.

Released: 24-Oct-2023 1:35 PM EDT
From nanoplastics to airborne toxins: Pollution stories for media.
Newswise

Read the latest research news on air pollution, nanoplastics, waterborne illnesses and more in the Pollution channel on Newswise.

       
Released: 12-Oct-2023 9:05 AM EDT
Association for Molecular Pathology Publishes Best Practice Recommendations for Liquid Biopsy Assay Validations
Association for Molecular Pathology

The Association for Molecular Pathology has published best practice recommendations for validating and reporting clinical circulating tumor DNA (ctDNA) or liquid biopsy assays and their related scientific publications.

Newswise: Could Ginger Help Treat Autoimmune Disease Symptoms?
Released: 11-Oct-2023 2:25 PM EDT
Could Ginger Help Treat Autoimmune Disease Symptoms?
Michigan Medicine - University of Michigan

After ginger root was proven to halt autoimmune disease progression in mice, researchers are now trialing the same concept in humans

Newswise: THE AUTOIMMUNE ASSOCIATION NAMES NEW CHAIR OF MEDICAL AND SCIENTIFIC ADVISORY COUNCIL
Released: 2-Oct-2023 8:00 AM EDT
THE AUTOIMMUNE ASSOCIATION NAMES NEW CHAIR OF MEDICAL AND SCIENTIFIC ADVISORY COUNCIL
Autoimmune Association

The Autoimmune Association announces the appointment of Eline (Nina) T. Luning Prak, MD, PhD, as chair of the organization’s Medical and Scientific Advisory Council.

Newswise: Study identifies new pathway to suppressing autoimmunity
25-Sep-2023 2:05 PM EDT
Study identifies new pathway to suppressing autoimmunity
The Rockefeller University Press

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body’s own, healthy tissues. The study, to be published September 29 in the Journal of Experimental Medicine (JEM), also reveals how this process is impaired in autoimmune disorders such as systemic sclerosis and systemic lupus erythematosus and suggests potential new strategies to treat these diseases.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 23-Aug-2023 1:25 PM EDT
Toppling siloes to link electronic dental and health records
Regenstrief Institute

A new study reports on linking electronic health records and electronic dental records to provide better care and outcomes for individuals with Sjögren's disease.

Released: 23-Aug-2023 12:45 PM EDT
Research identifies immunosuppressed people are least likely to have COVID-19 antibodies
University of Nottingham

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

Newswise: Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Released: 18-Aug-2023 12:05 PM EDT
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Johns Hopkins Medicine

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.

Newswise: UTSW finds potential key to predict immunotherapy toxicity
Released: 14-Aug-2023 11:50 AM EDT
UTSW finds potential key to predict immunotherapy toxicity
UT Southwestern Medical Center

Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to improved treatments for a variety of cancers.

Newswise: Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Released: 10-Aug-2023 9:05 AM EDT
Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Johns Hopkins Medicine

A new study of mice and lab-grown human colon “organoids” indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Newswise: Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder
Released: 10-Aug-2023 8:00 AM EDT
Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder
University of North Carolina School of Medicine

The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.

Newswise: Racial Discrimination Linked to Increased Inflammation Among Black Women with Systemic Lupus Erythematosus, Study Finds
Released: 8-Aug-2023 3:05 PM EDT
Racial Discrimination Linked to Increased Inflammation Among Black Women with Systemic Lupus Erythematosus, Study Finds
Ochsner Health

The research, focused on Black women with systemic lupus erythematosus (SLE), an inflammatory autoimmune disease, sheds light on the detrimental effects of psychosocial stress on health and the role of inflammatory mechanisms.

Released: 8-Aug-2023 11:10 AM EDT
Physical activity may prevent fatigue in patients with MS
University of Eastern Finland

A study led by the University of Eastern Finland found that better physical condition and higher daily activity predicted lower levels of fatigue in patients with relapsing-remitting multiple sclerosis, RRMS. A lower disability rate was also associated with less fatigue.

Released: 8-Aug-2023 11:00 AM EDT
Possible biomarker of MS-like autoimmune disease discovered
University of Basel

It has been known for several years that the diagnosis “multiple sclerosis” conceals a whole range of different illnesses, each requiring customized treatment. Researchers have now described a possible new MS-like disease and explained how to diagnose it.

Released: 1-Aug-2023 5:30 PM EDT
Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable
University of Gothenburg

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

Newswise: Illinois Team Identifies Key Driver of Cancer Cell Death Pathway That Activates Immune Cells
Released: 31-Jul-2023 11:50 AM EDT
Illinois Team Identifies Key Driver of Cancer Cell Death Pathway That Activates Immune Cells
College of Liberal Arts and Sciences, University of Illinois Urbana-Champaign

University of Illinois scientists have identified a protein that plays a critical role in the action of several emerging cancer therapies. The discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

   
Newswise: Researchers Discover Genetic Locations for Increased Risk of Hidradenitis Suppurativa
Released: 26-Jul-2023 3:05 PM EDT
Researchers Discover Genetic Locations for Increased Risk of Hidradenitis Suppurativa
University of North Carolina School of Medicine

Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disease which causes painful lumps to form under the skin. The lumps typically form in areas where skin rubs together – such as the armpits, groin, and under the breasts. HS can range in severity from occasional fluid-filled abscesses to widespread rope-like scarring, chronic pain, and increase of infection.

24-Jul-2023 9:10 AM EDT
Experts call for urgent mental health support for people living with long term autoimmune diseases
University of Cambridge

Study finds ‘startling’ levels of hidden mental health symptoms among autoimmune disease patients.

19-Jul-2023 10:00 AM EDT
Artificial Intelligence Models Predict Multiple Sclerosis, Detect Contaminated Lab Samples
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new artificial intelligence model can predict people’s risk of multiple sclerosis years before diagnosis, potentially enabling quicker treatment, according to research revealed today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.

Released: 24-Jul-2023 12:05 PM EDT
Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company
Rutgers University's Office for Research

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.



close
2.08383